Package 51655-115-83

{"route": ["ORAL"], "spl_id": "48c3c65d-777b-3c63-e063-6394a90a1176", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["f2b3939b-a410-6354-e053-2995a90ababb"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-25)", "package_ndc": "51655-115-25", "marketing_start_date": "20221005"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-26)", "package_ndc": "51655-115-26", "marketing_start_date": "20221115"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-52)", "package_ndc": "51655-115-52", "marketing_start_date": "20221130"}, {"sample": false, "description": "180 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-115-83)", "package_ndc": "51655-115-83", "marketing_start_date": "20230105"}], "brand_name": "Bupropion Hydrochloride SR", "product_id": "51655-115_48c3c65d-777b-3c63-e063-6394a90a1176", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "51655-115", "generic_name": "bupropion hydrochloride", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA211347", "marketing_category": "ANDA", "marketing_start_date": "20221005", "listing_expiration_date": "20271231"}